+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Invasive Fungal Infection Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report

  • 180 Pages
  • December 2023
  • Region: Global
  • Infinium Global Research
  • ID: 5557593
Description Jump to:
The report on the global invasive fungal infection market provides qualitative and quantitative analysis for the period from 2021-2030. The global invasive fungal infection market was valued at USD 6.61 billion in 2022 and is expected to reach USD 9.06 billion in 2030, with a CAGR of 4.04% during the forecast period 2023-2030. The study on invasive fungal infection market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

The report on invasive fungal infection market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global invasive fungal infection market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global invasive fungal infection market over the period of 2021-2030. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • The invasive fungal infection market is driven by the increasing incidence of immunocompromised patients.
  • Rapid advancements in medical technology and diagnostics fuel the market growth.

2) Restraints

  • The complexity in developing new antifungal therapies can act as a barrier to the market growth.

3) Opportunities

  • The continuous evolution of antifungal therapies, and treatment strategies, presents a promising opportunity for the invasive fungal infection market.

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global invasive fungal infection market is segmented on the basis of disease type, and drug type.

The Global Invasive Fungal Infection Market by Disease Type

  • Candidemia and Invasive Candidiasis
  • Intra-abdominal Candidiasis
  • Cryptococcal Meningitis
  • Esophageal Candidiasis
  • Histoplasmosis Acute Pulmonary
  • Invasive Aspergillosis
  • Invasive Fungal Rhinosinusitis
  • Mucormycosis
  • Others

The Global Invasive Fungal Infection Market by Drug Type

  • Polyenes
  • Amphotericin B Deoxycholate
  • Lipid Formulation Amphotericin B
  • Others

Company Profiles

The companies covered in the report include
  • Basilea Pharmaceutica Ltd.
  • Pfizer Inc.
  • GSK plc.
  • Bayer AG
  • BIOSERGEN
  • Merck & Co., Inc.
  • Astellas Pharma Inc.
  • SCYNEXIS, Inc.
  • Cidara Therapeutics, Inc.
  • F2G

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the invasive fungal infection market.
2. Complete coverage of all the segments in the invasive fungal infection market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global invasive fungal infection market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Invasive Fungal Infection Market Highlights
2.2. Invasive Fungal Infection Market Projection
2.3. Invasive Fungal Infection Market Regional Highlights
Chapter 3. Global Invasive Fungal Infection Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Disease Type
3.4.2. Growth Matrix Analysis by Drug Type
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Invasive Fungal Infection Market
Chapter 4. Invasive Fungal Infection Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Invasive Fungal Infection Market
5.2. Companies Profiles
5.2.1. Basilea Pharmaceutica Ltd.
5.2.2. Pfizer Inc.
5.2.3. GSK plc.
5.2.4. Bayer AG
5.2.5. BIOSERGEN
5.2.6. Merck & Co., Inc.
5.2.7. Astellas Pharma Inc.
5.2.8. SCYNEXIS, Inc.
5.2.9. Cidara Therapeutics, Inc.
5.2.10. F2G
Chapter 6. Global Invasive Fungal Infection Market by Disease Type
6.1. Candidemia and Invasive Candidiasis
6.2. Intra-abdominal Candidiasis
6.3. Cryptococcal Meningitis
6.4. Esophageal Candidiasis
6.5. Histoplasmosis Acute Pulmonary
6.6. Invasive Aspergillosis
6.7. Invasive Fungal Rhinosinusitis
6.8. Mucormycosis
6.9. Others
Chapter 7. Global Invasive Fungal Infection Market by Drug Type
7.1. Polyenes
7.2. Amphotericin B Deoxycholate
7.3. Lipid Formulation Amphotericin B
7.4. Others
Chapter 8. Global Invasive Fungal Infection Market by Region 2023-2030
8.1. North America
8.1.1. North America Invasive Fungal Infection Market by Disease Type
8.1.2. North America Invasive Fungal Infection Market by Drug Type
8.1.3. North America Invasive Fungal Infection Market by Country
8.1.3.1. The U.S. Invasive Fungal Infection Market
8.1.3.1.1. The U.S. Invasive Fungal Infection Market by Disease Type
8.1.3.1.2. The U.S. Invasive Fungal Infection Market by Drug Type
8.1.3.2. Canada Invasive Fungal Infection Market
8.1.3.2.1. Canada Invasive Fungal Infection Market by Disease Type
8.1.3.2.2. Canada Invasive Fungal Infection Market by Drug Type
8.1.3.3. Mexico Invasive Fungal Infection Market
8.1.3.3.1. Mexico Invasive Fungal Infection Market by Disease Type
8.1.3.3.2. Mexico Invasive Fungal Infection Market by Drug Type
8.2. Europe
8.2.1. Europe Invasive Fungal Infection Market by Disease Type
8.2.2. Europe Invasive Fungal Infection Market by Drug Type
8.2.3. Europe Invasive Fungal Infection Market by Country
8.2.3.1. Germany Invasive Fungal Infection Market
8.2.3.1.1. Germany Invasive Fungal Infection Market by Disease Type
8.2.3.1.2. Germany Invasive Fungal Infection Market by Drug Type
8.2.3.2. United Kingdom Invasive Fungal Infection Market
8.2.3.2.1. United Kingdom Invasive Fungal Infection Market by Disease Type
8.2.3.2.2. United Kingdom Invasive Fungal Infection Market by Drug Type
8.2.3.3. France Invasive Fungal Infection Market
8.2.3.3.1. France Invasive Fungal Infection Market by Disease Type
8.2.3.3.2. France Invasive Fungal Infection Market by Drug Type
8.2.3.4. Italy Invasive Fungal Infection Market
8.2.3.4.1. Italy Invasive Fungal Infection Market by Disease Type
8.2.3.4.2. Italy Invasive Fungal Infection Market by Drug Type
8.2.3.5. Rest of Europe Invasive Fungal Infection Market
8.2.3.5.1. Rest of Europe Invasive Fungal Infection Market by Disease Type
8.2.3.5.2. Rest of Europe Invasive Fungal Infection Market by Drug Type
8.3. Asia Pacific
8.3.1. Asia Pacific Invasive Fungal Infection Market by Disease Type
8.3.2. Asia Pacific Invasive Fungal Infection Market by Drug Type
8.3.3. Asia Pacific Invasive Fungal Infection Market by Country
8.3.3.1. China Invasive Fungal Infection Market
8.3.3.1.1. China Invasive Fungal Infection Market by Disease Type
8.3.3.1.2. China Invasive Fungal Infection Market by Drug Type
8.3.3.2. Japan Invasive Fungal Infection Market
8.3.3.2.1. Japan Invasive Fungal Infection Market by Disease Type
8.3.3.2.2. Japan Invasive Fungal Infection Market by Drug Type
8.3.3.3. India Invasive Fungal Infection Market
8.3.3.3.1. India Invasive Fungal Infection Market by Disease Type
8.3.3.3.2. India Invasive Fungal Infection Market by Drug Type
8.3.3.4. South Korea Invasive Fungal Infection Market
8.3.3.4.1. South Korea Invasive Fungal Infection Market by Disease Type
8.3.3.4.2. South Korea Invasive Fungal Infection Market by Drug Type
8.3.3.5. Australia Invasive Fungal Infection Market
8.3.3.5.1. Australia Invasive Fungal Infection Market by Disease Type
8.3.3.5.2. Australia Invasive Fungal Infection Market by Drug Type
8.3.3.6. Rest of Asia-Pacific Invasive Fungal Infection Market
8.3.3.6.1. Rest of Asia-Pacific Invasive Fungal Infection Market by Disease Type
8.3.3.6.2. Rest of Asia-Pacific Invasive Fungal Infection Market by Drug Type
8.4. RoW
8.4.1. RoW Invasive Fungal Infection Market by Disease Type
8.4.2. RoW Invasive Fungal Infection Market by Drug Type
8.4.3. RoW Invasive Fungal Infection Market by Sub-region
8.4.3.1. Latin America Invasive Fungal Infection Market
8.4.3.1.1. Latin America Invasive Fungal Infection Market by Disease Type
8.4.3.1.2. Latin America Invasive Fungal Infection Market by Drug Type
8.4.3.2. Middle East Invasive Fungal Infection Market
8.4.3.2.1. Middle East Invasive Fungal Infection Market by Disease Type
8.4.3.2.2. Middle East Invasive Fungal Infection Market by Drug Type
8.4.3.3. Africa Invasive Fungal Infection Market
8.4.3.3.1. Africa Invasive Fungal Infection Market by Disease Type
8.4.3.3.2. Africa Invasive Fungal Infection Market by Drug Type

Companies Mentioned

  • Basilea Pharmaceutica Ltd.
  • Pfizer Inc.
  • GSK plc.
  • Bayer AG
  • BIOSERGEN
  • Merck & Co., Inc.
  • Astellas Pharma Inc.
  • SCYNEXIS, Inc.
  • Cidara Therapeutics, Inc.
  • F2G

Table Information

Report AttributeDetails
No. of Pages180
PublishedDecember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 6.61 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.06 Billion
Compound Annual Growth Rate4.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Invasive Fungal Infections Global Market Report 2024 - Product Image

Invasive Fungal Infections Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Argentina Invasive Fungal Infection Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Image

Argentina Invasive Fungal Infection Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • 80 Pages
  • Argentina
From
Poland Invasive Fungal Infection Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Image

Poland Invasive Fungal Infection Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • 80 Pages
  • Poland
From
Anti Fungal Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Anti Fungal Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • 150 Pages
  • Global
From
Systemic Aspergillosis and Systemic Candidiasis Global Market Report 2024 - Product Image

Systemic Aspergillosis and Systemic Candidiasis Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From

About the Invasive Fungal Infection Drug Market

The Invasive Fungal Infection Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat fungal infections that have spread beyond the skin and mucous membranes and into the bloodstream or organs. These drugs are used to treat a variety of fungal infections, including candidiasis, aspergillosis, and cryptococcosis. The drugs used to treat these infections are antifungal agents, such as azoles, echinocandins, and polyenes. These drugs are used to treat both acute and chronic fungal infections, and are often used in combination with other drugs. The Invasive Fungal Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, Novartis, AstraZeneca, and GlaxoSmithKline. Other companies in the market include Sanofi, Johnson & Johnson, Bayer, and Allergan. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.